177 related articles for article (PubMed ID: 27416796)
41. Comparison of chemoradiotherapy with and without brachytherapy as adjuvant therapy after radical surgery in early-stage cervical cancer with poor prognostic factors: An observational study.
Lan ML; Yu X; Xiao H; Zhou P; Hu N; Liu Y; Wang G
Medicine (Baltimore); 2017 Nov; 96(46):e8384. PubMed ID: 29145247
[TBL] [Abstract][Full Text] [Related]
42. Results of external-beam radiotherapy alone in invasive cancer of the uterine cervix: a retrospective analysis.
Saibishkumar EP; Patel FD; Sharma SC; Karunanidhi G; Sankar AS; Mallick I
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):46-51. PubMed ID: 16477919
[TBL] [Abstract][Full Text] [Related]
43. External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer.
Ariga T; Toita T; Kasuya G; Nagai Y; Inamine M; Kudaka W; Kakinohana Y; Aoki Y; Murayama S
J Radiat Res; 2013 Jul; 54(4):690-6. PubMed ID: 23365264
[TBL] [Abstract][Full Text] [Related]
44. Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.
Lin AJ; Samson P; Zoberi J; Garcia-Ramirez J; Williamson JF; Markovina S; Schwarz J; Grigsby PW
Brachytherapy; 2019; 18(3):353-360. PubMed ID: 30971370
[TBL] [Abstract][Full Text] [Related]
45. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE).
Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Huang EY; Hsiung CY; Changchien CC
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):85-91. PubMed ID: 9422562
[TBL] [Abstract][Full Text] [Related]
46. A phase 2 randomized controlled trial of oral resistant starch supplements in the prevention of acute radiation proctitis in patients treated for cervical cancer.
Sasidharan BK; Ramadass B; Viswanathan PN; Samuel P; Gowri M; Pugazhendhi S; Ramakrishna BS
J Cancer Res Ther; 2019; 15(6):1383-1391. PubMed ID: 31898677
[TBL] [Abstract][Full Text] [Related]
47. Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicity.
Chopra S; Dora T; Engineer R; Mechanery S; Agarwal P; Kannan S; Ghadi Y; Swamidas J; Mahantshetty U; Shrivastava SK
Brachytherapy; 2015; 14(6):881-8. PubMed ID: 26409708
[TBL] [Abstract][Full Text] [Related]
48. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
[TBL] [Abstract][Full Text] [Related]
49. Possible risk factors associated with radiation proctitis or radiation cystitis in patients with cervical carcinoma after radiotherapy.
Yang L; Lv Y
Asian Pac J Cancer Prev; 2012; 13(12):6251-5. PubMed ID: 23464440
[TBL] [Abstract][Full Text] [Related]
50. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
[TBL] [Abstract][Full Text] [Related]
51. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
52. Percutaneous parametrial dose escalation in women with advanced cervical cancer: feasibility and efficacy in relation to long-term quality of life.
Akbaba S; Oelmann-Avendano JT; Bostel T; Rief H; Nicolay NH; Debus J; Lindel K; Foerster R
Radiol Oncol; 2018 Sep; 52(3):320-328. PubMed ID: 30210042
[TBL] [Abstract][Full Text] [Related]
53. Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study.
Zhang N; Tang Y; Guo X; Mao Z; Yang W; Cheng G
Brachytherapy; 2020; 19(2):194-200. PubMed ID: 31791712
[TBL] [Abstract][Full Text] [Related]
54. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
55. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
[No Abstract] [Full Text] [Related]
56. The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy.
Chen SW; Liang JA; Yang SN; Liu RT; Lin FJ
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):955-61. PubMed ID: 10863065
[TBL] [Abstract][Full Text] [Related]
57. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
Hu K; Wang W; Liu X; Meng Q; Zhang F
Radiat Oncol; 2018 Dec; 13(1):249. PubMed ID: 30558636
[TBL] [Abstract][Full Text] [Related]
58. Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
Wujanto C; Choo BA; Tan D; Ilancheran A; Ng J; Low JJH; Shen L; Tang J; Koh V
BMC Cancer; 2019 Apr; 19(1):385. PubMed ID: 31023261
[TBL] [Abstract][Full Text] [Related]
59. Daily low-dose Cisplatin-based concurrent chemoradiotherapy for the treatment of cervical cancer in patients 70 years or older.
Hanawa S; Mitsuhashi A; Usui H; Yamamoto N; Watanabe-Nemoto M; Nishikimi K; Uehara T; Tate S; Uno T; Shozu M
Int J Gynecol Cancer; 2015 Jun; 25(5):891-6. PubMed ID: 25811592
[TBL] [Abstract][Full Text] [Related]
60. Long-term results for Stage IIIB cervical cancer patients receiving external beam radiotherapy combined with either HDR (252)Cf or HDR (60)Co intracavitary brachytherapy.
Ulinskas K; Janulionis E; Valuckas KP; Samerdokiene V; Atkocius V; Rivard MJ
Brachytherapy; 2016; 15(3):353-360. PubMed ID: 26996594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
